Novosanis Overview
- Year Founded
-
2013
- Status
-
Acquired/Merged
- Employees
-
20
- Latest Deal Type
-
M&A
- Investors
-
1
Novosanis General Information
Description
Manufacturer and developer of medical devices designed to improve the quality of diagnostic tests as well as the accuracy of drug delivery. The company's devices range from injection appliances to in vitro diagnostic accessories suited for the collection of first-void urine, which improves the diagnosis of sexually transmitted infections and cancer, thereby helping physicians treat patients.
Contact Information
Website
www.novosanis.comCorporate Office
- Bijkhoevelaan 32c
- 2110 Wijnegem
- Belgium
Corporate Office
- Bijkhoevelaan 32c
- 2110 Wijnegem
- Belgium
Novosanis Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Merger/Acquisition | 04-Jan-2019 | Completed | Generating Revenue | |||
| 7. Angel (individual) | 10-Jul-2018 | Completed | Generating Revenue | |||
| 6. Grant | 04-Apr-2017 | Completed | Generating Revenue | |||
| 5. Angel (individual) | 26-Jan-2017 | Completed | Generating Revenue | |||
| 4. Grant | 15-Sep-2015 | Completed | Generating Revenue | |||
| 3. Grant | 13-Aug-2014 | Completed | Generating Revenue | |||
| 2. Seed Round | 19-Jul-2013 | $636K | $636K | Completed | Generating Revenue | |
| 1. University Spin-Out | 12-Mar-2013 | Completed | Startup |
Novosanis Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Class B | ||||||||
| Class A | ||||||||
| Class B | ||||||||
| Class A | ||||||||
| Class B | ||||||||
| Class A | ||||||||
| Class B | ||||||||
| Class A | ||||||||
| Class B | 18,000 | $24.97 | $24.97 | 1x | $24.97 | 8.82% | ||
| Class B | 20,000 | $28.43 | $28.43 | 1x | $28.43 | 9.8% |
Novosanis Comparisons
Industry
Financing
Details
Novosanis Competitors (11)
One of Novosanis’s 11 competitors is BacterioScan, a Formerly VC-backed company based in Saint Louis, MO.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| BacterioScan | Formerly VC-backed | Saint Louis, MO | ||||
| ELITechGroup | Formerly PE-Backed | Puteaux, France | ||||
| LEX Diagnostics | Corporate Backed or Acquired | Melbourn, United Kingdom | ||||
| Advanced Molecular Diagnostics | Corporation | Nottingham, United Kingdom | ||||
| Biocartis | Venture Capital-Backed | Mechelen, Belgium |
Novosanis Patents
Novosanis Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-217484-S | Floater for a liquid collection device | Active | 25-May-2022 | ||
| WO-2023227748-A1 | Liquid sampler for fast capture of initial volume of a liquid flow | Inactive | 25-May-2022 | ||
| JP-7722988-B2 | Needle adapter and assembly for forming an injection device for administering a fluid to a subject - patent application 20070122997 | Active | 16-Oct-2019 | ||
| JP-2022552866-A | Needle adapter and assembly for forming an injection device for administering fluid to a subject | Active | 16-Oct-2019 | ||
| CA-3158194-A1 | Needle adaptor and assembly for forming an injection device for administering a fluid to a subject | Pending | 16-Oct-2019 | A61M5/32 |
Novosanis Signals
Novosanis Former Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Horizon 2020 | Government | Minority | ||
| Taste Westerlund | Family Office | Minority |
Novosanis FAQs
-
When was Novosanis founded?
Novosanis was founded in 2013.
-
Where is Novosanis headquartered?
Novosanis is headquartered in Wijnegem, Belgium.
-
What is the size of Novosanis?
Novosanis has 20 total employees.
-
What industry is Novosanis in?
Novosanis’s primary industry is Diagnostic Equipment.
-
Is Novosanis a private or public company?
Novosanis is a Private company.
-
What is Novosanis’s current revenue?
The current revenue for Novosanis is .
-
How much funding has Novosanis raised over time?
Novosanis has raised $2.12M.
-
Who are Novosanis’s investors?
Horizon 2020 and Taste Westerlund have invested in Novosanis.
-
Who are Novosanis’s competitors?
BacterioScan, ELITechGroup, LEX Diagnostics, Advanced Molecular Diagnostics, and Biocartis are some of the 11 competitors of Novosanis.
-
When was Novosanis acquired?
Novosanis was acquired on 04-Jan-2019.
-
Who acquired Novosanis?
Novosanis was acquired by Orasure Technologies.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process